The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,881.00
Bid: 1,880.00
Ask: 1,882.00
Change: 30.00 (1.62%)
Spread: 2.00 (0.106%)
Open: 1,853.00
High: 1,884.00
Low: 1,848.00
Prev. Close: 1,851.00
IMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Coronavirus update

30 Mar 2020 07:00

RNS Number : 9560H
IMI PLC
30 March 2020
 

30 March 2020

Coronavirus update

Given the current and rapidly changing developments regarding Coronavirus, IMI plc ('IMI'), the specialist engineering group, issues the following update. This announcement contains inside information.

Protecting our people

Even before the outbreak of the Coronavirus pandemic, our primary concern has always been the safety and well-being of our people, our wider communities, our customers and partners.

Over recent weeks, this commitment has assumed even greater relevance. All of our facilities have implemented additional personal protection measures, intensified hygiene, and social distancing protocols that meet or exceed local and international guidelines. Employees who are able have been working from home for some time. Factory operations have been managed safely and intensively to maximise business continuity and to support our customers.

A crisis response team comprising both divisional leadership and members of the Group Executive meets at least three times per week to closely monitor the situation and co-ordinate our response. We also communicate regularly with all our employees, keeping them informed about the evolving situation and offering guidance on how they can best keep themselves and their colleagues safe.

Financial position

We have entered this period of uncertainty in a strong financial position. As at the end of February, the Group had immediately available liquidity of £393m, comprising £19m of available cash, £293m of undrawn committed bank facilities with our six core relationship banks, and an additional £81m of undrawn uncommitted facilities.

The Group's existing long-term debt, totalling £363m, was raised through the US Private Placement market. This debt is at fixed rates and, aside from £11m due in 2022, matures in 2025 and beyond.

The financial covenants attached to our committed facilities are that EBITDA should be no less than 4 times interest and net debt should be no more than 3 times EBITDA. Those covenant ratios, at 31 December 2019, were 24.0 times and 1.2 times, respectively.

Recent trading

The disruption from Coronavirus to our businesses in the first two months of the year has been relatively modest - with sales and orders being slightly ahead of our earlier guidance. Margins and cash flow remained strong.

The majority of our sites remain at or near normal capacity. Some facilities, which support IMI Precision Engineering's Life Science sector, have received special dispensation to accelerate activity, in order to ramp-up production of key valve components for the world's ventilator manufacturers.

Our operations in China were disrupted for two weeks in early February, but have since returned to normal operations.  However, in some locations, including in Italy and India, sites have had to close temporarily in line with the direction of the authorities. It is expected that site and supply chain disruptions will likely increase in the short-term before global industrial activity returns to normal.

Protecting our future

Whilst we look forward to, and remain confident of, a return to normal trading, we are actively preparing for the short-term disruptions and expected macroeconomic declines brought about by this pandemic. Mitigating actions have already been taken in anticipation of tougher conditions, including a hiring freeze in all but exceptional circumstances, reduced discretionary spending, and reductions to capital expenditure unless vital for health and safety or operations continuity. The Board and Executive Committee members have agreed to a 20% salary reduction, effective 1 May, for at least the next three months.

 

Further cost reduction initiatives are being developed in order to enable the organisation to align its cost base with any reduced market demand. Our leadership is in close communication with key customers around the world to provide them with our support and expertise, and to minimise misalignment as we progress the year.

 

Dividend

Although we remain confident in the strength of our financial position, given the unprecedented business uncertainty brought about by the pandemic, the Board has decided to withdraw its recommendation to pay a final dividend at the AGM in May, thereby preserving £71m of funds to support the long-term position of the Group. This is recognised as a significant decision and one that will be reviewed later in the year, once the trading environment and outlook become clearer.

 

Outlook and guidance

When we presented our 2019 preliminary results on 28 February, we offered guidance for the first half of 2020, subject to the evolving Coronavirus situation. Although the impact on our trading to date has been relatively modest, given the significant volatility within our market environment, we believe it is now prudent to withdraw that guidance. We will continue to offer updates as it becomes appropriate and helpful to do so. Our next formal communication will be the Interim Management Statement planned for release on 7 May 2020.

 

Roy Twite, Chief Executive said "I am incredibly proud and humbled by the commitment, courage and professionalism shown by all our employees as we face this unprecedented disruption to our communities and businesses. It is my firm belief that, by continuing to act decisively, IMI will deliver on its ambitious strategy once this global, human tragedy has been resolved."

 

Enquiries to:

John Dean

IMI

Tel: +44 (0)121 717 3712

Gayden Metcalfe

Teneo

Tel: +44 (0)20 7420 3189

 

The Annual Report is available on the IMI plc website and will be issued along with the Notice of Meeting to shareholders on 2 April 2020.

 

Notes to editors

IMI plc, the specialist engineering company, designs, manufactures and services highly engineered products that control the precise movement of fluids. Its innovative technologies, built around valves and actuators, enable vital processes to operate safely, cleanly, efficiently and cost effectively. The Group works with industrial customers across a range of high growth sectors, including energy, transportation and infrastructure, all of which are benefiting from the impact of long-term global trends including climate change, urbanisation, resource scarcity and an ageing population. IMI employs around 11,000 people, has manufacturing facilities in more than 20 countries and operates a global service network. The Company is listed on the London Stock Exchange. Further information is available at www.imiplc.com.

 

IMI plc is registered in England No. 714275. Its legal entity identifier ('LEI') number is 2138002W9Q21PF751R30.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDDKLFLBXLXBBX
Date   Source Headline
9th May 20241:19 pmRNSResult of AGM
9th May 20247:00 amRNSInterim Management Statement
1st May 20242:56 pmRNSDirector/PDMR Shareholding
1st May 20242:20 pmRNSTotal Voting Rights
12th Apr 20241:49 pmRNSDirector/PDMR Shareholding
10th Apr 20241:42 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:50 pmRNSTotal Voting Rights
28th Mar 20249:11 amRNSAnnual Financial Report
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
20th Mar 202411:37 amRNSDirector/PDMR Shareholding
14th Mar 20248:58 amRNSRetail Investor Webinar
13th Mar 20241:58 pmRNSDirector/PDMR Shareholding
1st Mar 20241:58 pmRNSTotal Voting Rights
1st Mar 20241:57 pmRNSDirector Declaration
1st Mar 20247:00 amRNSPreliminary Results
29th Feb 202410:09 amRNSDirectorate Change
27th Feb 20248:54 amRNSHolding(s) in Company
14th Feb 202411:35 amRNSDirector/PDMR Shareholding
1st Feb 202411:28 amRNSTotal Voting Rights
30th Jan 202411:02 amRNSDirectorate Change
10th Jan 20241:01 pmRNSDirector/PDMR Shareholding
2nd Jan 202411:35 amRNSBlock listing Interim Review
2nd Jan 202411:04 amRNSTotal Voting Rights
19th Dec 20239:55 amRNSDirector/PDMR Shareholding
13th Dec 20233:41 pmRNSDirector/PDMR Shareholding
5th Dec 20239:28 amRNSDirector Declaration
1st Dec 20231:30 pmRNSTotal Voting Rights
15th Nov 20231:42 pmRNSDirector/PDMR Shareholding
9th Nov 20237:01 amRNSHistorical Financial Information
9th Nov 20237:00 amRNSInterim Management Statement
1st Nov 202312:42 pmRNSTotal Voting Rights
11th Oct 20233:20 pmRNSDirector/PDMR Shareholding
2nd Oct 20231:19 pmRNSTotal Voting Rights
13th Sep 20233:32 pmRNSDirector/PDMR Shareholding
1st Sep 202311:29 amRNSTotal Voting Rights
10th Aug 20234:53 pmRNSDirector/PDMR Shareholding
10th Aug 20234:38 pmRNSDirector/PDMR Shareholding
9th Aug 20232:34 pmRNSDirector/PDMR Shareholding
1st Aug 202310:16 amRNSTotal Voting Rights
31st Jul 20231:52 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSInterim Results
12th Jul 20231:13 pmRNSDirector/PDMR Shareholding
3rd Jul 20232:58 pmRNSBlock listing Interim Review
3rd Jul 20232:41 pmRNSTotal Voting Rights
26th Jun 20234:39 pmRNSHolding(s) in Company
14th Jun 202310:48 amRNSDirector/PDMR Shareholding
8th Jun 20233:18 pmRNSDirector/PDMR Shareholding
1st Jun 20231:51 pmRNSTotal Voting Rights
22nd May 202310:18 amRNSDirectorate Change
11th May 202311:49 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.